Search
-
Searchresult: The Biopharmaceutical Production & Development Unit (BP&DU)
The Biopharmaceutical Production & Development Unit (BP&DU) supports research-associated topics Viral vectors and oncolytic viruses Large Scale production and purification of parvovirus (vector)…
-
Searchresult: Thioredoxin scaffolds for therapeutic vaccination
Xueer Zhao, PhD student Introduction The tumor suppressor p16INK4a is strongly expressed in HPV-transformed precursor lesions and HPV-associated cancer, whereas in normal tissues barely…
-
Searchresult: Re-engineering nano particle HPV prophylactic vaccine based on minor capsid protein L2
Fan Yang, PhD student Introduction The N-terminus of the HPV minor capsid protein L2 contains several epitopes which are able to elicit neutralizing antibodies with the ability of cross…
-
Searchresult: Our team
-
Searchresult: PANHPVAX
PANHPVAX structure of vaccine antigen Introduction Infections with one of 15 human papillomavirus (HPV) types are considered the main risk factor for the development of certain anogenital…
-
Searchresult: Our team
-
Searchresult: Our team
-
Searchresult: Our team
Head of Department Deputy Heads Administrative Assistants Budget and Personnel Management Data Management Scientific…
-
Searchresult: Translational Lymphoma Research
Our Research In recent years a number of novel therapeutic strategies (kinase inhibitors, inhibitors of the anti-apoptotic molecule BCL2, monoclonal antibodies, CAR T cells, antibody-drug…
-
Searchresult: Translational Radiotheranostics
What drives us ? At the heart of our research lies the Targeted Radionuclide Therapy (TRNT), an innovative method of fighting cancer. In TRNT, selective binding motifs transport radionuclides to…